Page last updated: 2024-10-18

dimethyl sulfoxide and a-Synucleinopathies

dimethyl sulfoxide has been researched along with a-Synucleinopathies in 1 studies

Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.

Research Excerpts

ExcerptRelevanceReference
"Dimethyl sulfoxide (DMSO) is a highly utilized small molecule that serves many purposes in scientific research."1.72Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synuclein. ( Baun, A; Gram, H; Haikal, C; Jensen, PH; Kovacs, G; Li, JY; Nielsen, J; Otzen, DE; Reimer, L; Ruesink, H; Theologidis, V, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Reimer, L1
Haikal, C1
Gram, H1
Theologidis, V1
Kovacs, G1
Ruesink, H1
Baun, A1
Nielsen, J1
Otzen, DE1
Li, JY1
Jensen, PH1

Other Studies

1 other study available for dimethyl sulfoxide and a-Synucleinopathies

ArticleYear
Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synuclein.
    Scientific reports, 2022, 03-08, Volume: 12, Issue:1

    Topics: alpha-Synuclein; Animals; Dimethyl Sulfoxide; Mice; Mice, Inbred C57BL; Mice, Transgenic; Parkinson

2022